Polaris Peptides
Polaris Peptides' stronger purity-focus evidence sits in Tirzepatide and improving Retatrutide after earlier purity misses. The record is dispersed rather than uniform: BPC-157 has repeated recent purity failures, GHK-Cu shows fill overages, and some otherwise current, high-volume evidence lacks batch IDs.
We investigated who actually operates Polaris Peptides — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Polaris Peptides rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
| 13 May 2026 | Pass | Retatrutide Polaris Peptides | lab name | View COA | |||
| 13 May 2026 | Fail | BPC-157 Polaris Peptides | lab name | View COA | |||
| 19 Jan 2026 | Fail | Tirzepatide Polaris Peptides | lab name | View COA | |||
| 7 Jan 2026 | Pass | Retatrutide Polaris Peptides | lab name | View COA | |||
| 25 Nov 2025 | Fail | GHK-Cu Polaris Peptides | lab name | View COA | |||
| 7 Nov 2025 | Fail | GHK-Cu Polaris Peptides | lab name | View COA | |||
| 9 Oct 2025 | Pass | Retatrutide Polaris Peptides | lab name | View COA | |||
| 1 Oct 2025 | Fail | BPC-157 Polaris Peptides | lab name | View COA | |||
| 1 Oct 2025 | Fail | BPC-157 Polaris Peptides | lab name | View COA | |||
| 19 Aug 2025 | Fail | PT-141 Polaris Peptides | lab name | View COA | |||
About Polaris Peptides test results from Finnrick
Polaris Peptides is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 9 peptides and 99 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Polaris Peptides peptides in this dataset are Semaglutide (17 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 99 recent tests.